Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Comperat

Showing results (101-110 of 161) with videos related to

Pageof 17
Sort By:
The American Journal of Surgical Pathology|June 14, 2019
Data Set for the Reporting of Carcinoma of the Renal Pelvis and Ureter-Nephroureterectomy and Ureterectomy Specimens: Recommendations From the International Collaboration on Cancer Reporting (ICCR)Hemamali Samaratunga, Meagan Judge, Brett Delahunt, et al.
Histopathology|April 23, 2019
Dataset for reporting of carcinoma of the urethra (in urethrectomy specimens): recommendations from the International Collaboration on Cancer Reporting (ICCR)Jonathan H Shanks, John R Srigley, Fadi Brimo, et al.
World Journal of Urology|May 10, 2014
Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomySophie Hurel, Morgan Rouprêt, Thomas Seisen, et al.
World Journal of Urology|August 3, 2013
Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinomaAlexandra Masson-Lecomte, Pierre Colin, Gregory Bozzini, et al.
The Prostate|July 13, 2017
Ductal adenocarcinoma of the prostate: Clinical and biological profilesArmelle Vinceneux, Franck Bruyère, Olivier Haillot, et al.
World Journal of Urology|April 22, 2018
Comparison of cell cycle progression score with two immunohistochemical markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomyPriscilla Léon, Geraldine Cancel-Tassin, Sara Drouin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinomaMorgan Rouprêt, Géraldine Cancel-Tassin, Eva Comperat, et al.
European Urology Oncology|February 17, 2020
Urothelial Cancers with Small Cell Variant Histology Have Confirmed High Tumor Mutational Burden, Frequent TP53 and RB Mutations, and a Unique Gene Expression ProfileJean Hoffman-Censits, Woonyoung Choi, Sumanta Pal, et al.
Histopathology|August 28, 2015
Tubulocystic renal cell carcinoma is an entity that is immunohistochemically and genetically distinct from papillary renal cell carcinomaThu Tran, Carol L Jones, Sean R Williamson, et al.
European Urology|September 18, 2012
ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladderMaximilian Burger, Willem Oosterlinck, Badrinath Konety, et al.
Pageof 17

Showing results (101-110 of 161) with videos related to

Sort By:
Pageof 17
The American Journal of Surgical Pathology|June 14, 2019
Data Set for the Reporting of Carcinoma of the Renal Pelvis and Ureter-Nephroureterectomy and Ureterectomy Specimens: Recommendations From the International Collaboration on Cancer Reporting (ICCR)Hemamali Samaratunga, Meagan Judge, Brett Delahunt, et al.
Histopathology|April 23, 2019
Dataset for reporting of carcinoma of the urethra (in urethrectomy specimens): recommendations from the International Collaboration on Cancer Reporting (ICCR)Jonathan H Shanks, John R Srigley, Fadi Brimo, et al.
World Journal of Urology|May 10, 2014
Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomySophie Hurel, Morgan Rouprêt, Thomas Seisen, et al.
World Journal of Urology|August 3, 2013
Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinomaAlexandra Masson-Lecomte, Pierre Colin, Gregory Bozzini, et al.
The Prostate|July 13, 2017
Ductal adenocarcinoma of the prostate: Clinical and biological profilesArmelle Vinceneux, Franck Bruyère, Olivier Haillot, et al.
World Journal of Urology|April 22, 2018
Comparison of cell cycle progression score with two immunohistochemical markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomyPriscilla Léon, Geraldine Cancel-Tassin, Sara Drouin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinomaMorgan Rouprêt, Géraldine Cancel-Tassin, Eva Comperat, et al.
European Urology Oncology|February 17, 2020
Urothelial Cancers with Small Cell Variant Histology Have Confirmed High Tumor Mutational Burden, Frequent TP53 and RB Mutations, and a Unique Gene Expression ProfileJean Hoffman-Censits, Woonyoung Choi, Sumanta Pal, et al.
Histopathology|August 28, 2015
Tubulocystic renal cell carcinoma is an entity that is immunohistochemically and genetically distinct from papillary renal cell carcinomaThu Tran, Carol L Jones, Sean R Williamson, et al.
European Urology|September 18, 2012
ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladderMaximilian Burger, Willem Oosterlinck, Badrinath Konety, et al.
Pageof 17